SCHEMBL23871572

SCHEMBL23871572

CC(C)(C)OC(=O)NCCOc1cc2c(c(C=N)n1)CC(C=O)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.36
▸ CA1 P00915 3/20 0.36
▸ CA2 P00918 3/20 0.36
▸ CA9 Q16790 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ IDO1 P14902 1/20 0.34
▸ PDK2 Q15119 1/20 0.33
▸ STK17B O94768 1/20 0.33
▸ STK17A Q9UEE5 1/20 0.33
▸ CKS1B P61024 1/20 0.32
▸ SKP1 P63208 1/20 0.32
▸ SKP2 Q13309 1/20 0.32
▸ ADRB2 P07550 1/20 0.32
▸ HTR1A P08908 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ F2R P25116 1/20 0.32
▸ CNR1 P21554 1/20 0.31
▸ ATR Q13535 1/20 0.31
▸ ATRIP Q8WXE1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30046636 0.86 STK17B (0.38) CA12CA1CA2CA9KDM4E
SCHEMBL23871671 0.86 STK17B (0.38) CA12CA1CA2CA9KDM4E
SCHEMBL30047585 0.85 CA12 (0.36) CA12CA1CA2CA9KDM4E
SCHEMBL23871569 0.85 CA12 (0.36) CA12CA1CA2CA9KDM4E
SCHEMBL23857202 0.76 CA12 (0.46) CA12CA1CA2CA9IDO1
SCHEMBL23871521 0.75 CA12 (0.45) CA12CA1CA2CA9KDM4E
SCHEMBL30406809 0.74 CA12 (0.39) CA12CA1CA2CA9KDM4E
SCHEMBL23871636 0.74 CA12 (0.39) CA12CA1CA2CA9KDM4E
SCHEMBL23857034 0.73 CA12 (0.38) CA12CA1CA2CA9KDM4E
SCHEMBL23857101 0.73 STK17B (0.39) CA12CA1CA2CA9IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021190727-A1 COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2021-09-30 — — WO disclosed
Send feedback